Ejemplo: Heart Attack

Buscar ensayos clínicos para: S 1 (combination)

Total 399 resultados

NCT03129256

Completado

An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer

Condiciones: Non-small Cell Lung Cancer
NCT02704143

Completado

Combination of SBRT With Sequential S-1 for Treating Locally Advanced Pancreatic Cancer

Condiciones: Pancreatic Cancer
NCT03660449

Reclutamiento

Moderately Hypofractionated Conformal Radiation Combined With S-1 for Esophageal Squamous Cell Carcinoma

Condiciones: Esophageal Squamous Cell Carcinoma
NCT03977220

Aún no reclutando

Nab-paclitaxel Combined With S-1 Treating Diffuse Type of Stage Ⅲ Gastric Cancer

Condiciones: Gastric Cancer
NCT04338438

Completado

Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancer

Condiciones: Gastric Cancer
NCT02867397

Completado

Study of Teysuno (S-1) Combined With Epirubicin and Oxaliplatin in Patients With Advanced Solid Tumors

Condiciones: Patients With Advanced or Metastatic Solid Tumors
NCT01533324

Estado desconocido

S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)

Condiciones: Carcinoma; Liver Diseases; Hepatocellular Carcinoma
NCT04027764

Reclutamiento

Toripalimab Combined With S1 and Albumin Paclitaxel in Patients With Advanced Biliary Tract Cancer

Condiciones: Advanced Biliary Tract Cancer
NCT01854749

Completado

S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical Study

Condiciones: Esophageal Squamous Cell Carcinoma
NCT02677597

Estado desconocido

Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell Carcinoma

Condiciones: Esophageal Squamous Cell Carcinoma
NCT04047953

Aún no reclutando

Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy for Gastric Adenocarcinoma

Condiciones: Gastric Adenocarcinoma
NCT02855125

Completado

A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1

Condiciones: Advanced or Metastatic Non-small Cell Lung Cancer
NCT03320629

Estado desconocido

A Study of Apatinib Plus Radiotherapy and S-1 for Treatment of Refractory or Metastatic Esophageal Squamous Cell Carcinoma

Condiciones: Refractory or Metastatic Esophageal Squamous Cell Carcinoma
NCT01704690

Terminado

Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer

Condiciones: Esophageal Cancer
NCT00721916

Completado

Randomized Phase II Study of SOL for Untreated Metastatic Colorectal Cancer

Condiciones: Colorectal Cancer
NCT04258644

Aún no reclutando

Camrelizumab in Combination With Apatinib Mesylate, Paclitaxel-albumin and S-1 for Translational Treatment of Gastric Cancer

Condiciones: Gastric Cancer
NCT03950141

Reclutamiento

Apatinib Combined With S-1 as Maintenance Therapy for HER-2 Negatived Gastric Cancer

Condiciones: HER-2 Negatived Gastric Cancer
NCT01291407

Completado

A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer

Condiciones: Gastrointestinal Neoplasms; Gastric Cancer
NCT02618356

Estado desconocido

Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer

Condiciones: Metastatic Colon Cancer
NCT00891332

Completado

Study of S-1 Plus LV for Untreated Metastatic Colorectal Cancer

Condiciones: Colorectal Cancer
NCT02454062

Completado

A Trial of TAS-114 in Combination With S-1

Condiciones: Advanced Solid Tumors
NCT04128800

Reclutamiento

Appatinib Combined With S-1 in the Treatment of Small Cell Lung Cancer

Condiciones: Small Cell Lung Cancer
NCT00651833

Completado

Phase 2 Study of S-1 in Combination With Cisplatin as 1st Line Therapy in Advanced Non-Small Cell Lung Cancer

Condiciones: Advanced Non-Small Cell Lung Cancer
NCT03668366

Activo, no reclutando

S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

Condiciones: Nasopharyngeal Carcinoma
NCT03276156

Estado desconocido

Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer

Condiciones: Gastric Cancer